|
RREB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.625000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.396800E-04 |
| Normal-vs-Stage2 |
3.019600E-01 |
| Normal-vs-Stage3 |
8.903100E-03 |
| Normal-vs-Stage4 |
1.51156999999014E-05 |
| Stage1-vs-Stage2 |
3.984600E-01 |
| Stage1-vs-Stage3 |
6.862800E-01 |
| Stage1-vs-Stage4 |
8.452200E-02 |
| Stage2-vs-Stage3 |
3.185200E-01 |
| Stage2-vs-Stage4 |
4.107500E-02 |
| Stage3-vs-Stage4 |
1.468820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.645500E-04 |
| Normal-vs-AfricanAmerican |
8.081700E-03 |
| Normal-vs-Asian |
8.979800E-04 |
| Caucasian-vs-AfricanAmerican |
9.765800E-01 |
| Caucasian-vs-Asian |
2.946400E-01 |
| AfricanAmerican-vs-Asian |
2.686000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.834200E-04 |
| Normal-vs-Female |
4.468300E-02 |
| Male-vs-Female |
4.716000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.573600E-04 |
| Normal-vs-Extreme_Weight |
4.47260000000504E-05 |
| Normal-vs-Obese |
1.593960E-01 |
| Normal-vs-Extreme_Obese |
2.005400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.334400E-01 |
| Normal_Weight-vs-Obese |
5.156000E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.247000E-01 |
| Extreme_Weight-vs-Obese |
1.911820E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.887200E-01 |
| Obese-vs-Extreme_Obese |
6.014600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.260200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.090550E-01 |
| Normal-vs-Age(61-80Yrs) |
3.68280000000443E-05 |
| Normal-vs-Age(81-100Yrs) |
6.958000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.863400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.613400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.851200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.880600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.277900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.490600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.981930E-02 |
| Normal-VS-Type2 PRCC |
3.9305000000045E-05 |
| Normal-VS-KIRP CIMP |
2.05179999999139E-05 |
| Normal-VS-Unclassified PRCC |
7.304200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.510190E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.035600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.740000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.066600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.173810E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.364300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.59099999999368E-05 |
| Normal-vs-N1 |
2.350600E-04 |
| Normal-vs-N2 |
4.808100E-04 |
| N0-vs-N1 |
9.370600E-01 |
| N0-vs-N2 |
2.847700E-02 |
| N1-vs-N2 |
6.342400E-02 |
|
|
